BioCeuticals funds Phase II medicinal cannabis trial


Brain cancer

Scan showing brain cancer. Credit: Michelle Monje, MD, PhD, Stanford University.

BioCeuticals has provided funding for a Phase II clinical trial to investigate the impact of high THC medicinal cannabis on patients with glioma, a type of brain tumour.

Approved by Australia’s New South Wales (NSW) ministry of health, the trial will be led by Endeavour College of Natural Health clinical trials coordinator Dr Janet Schloss.

Neurosurgeon Charlie Teo will be an associate investigator of the trial and will lead patient

... read more at: https://www.drugdevelopment-technology.com/news/phase-ii-medicinal-cannabis-glioma/

by